Compare DSWL & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DSWL | COCH |
|---|---|---|
| Founded | 1987 | 1995 |
| Country | Macau | United States |
| Employees | N/A | 47 |
| Industry | Plastic Products | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.9M | 49.7M |
| IPO Year | 2000 | N/A |
| Metric | DSWL | COCH |
|---|---|---|
| Price | $3.46 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 19.7K | ★ 752.5K |
| Earning Date | 06-17-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.67 | $0.36 |
| 52 Week High | $4.48 | $1.89 |
| Indicator | DSWL | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 64.62 |
| Support Level | $3.19 | $0.64 |
| Resistance Level | $3.53 | $0.90 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 26.67 | 59.62 |
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.